1.55
price down icon1.90%   -0.03
pre-market  Vorhandelsmarkt:  1.54   -0.01   -0.65%
loading
Schlusskurs vom Vortag:
$1.58
Offen:
$1.59
24-Stunden-Volumen:
721.50K
Relative Volume:
0.48
Marktkapitalisierung:
$82.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-59.69M
KGV:
-1.1151
EPS:
-1.39
Netto-Cashflow:
$-46.54M
1W Leistung:
+4.03%
1M Leistung:
-16.67%
6M Leistung:
-21.72%
1J Leistung:
+2.65%
1-Tages-Spanne:
Value
$1.52
$1.59
1-Wochen-Bereich:
Value
$1.49
$1.64
52-Wochen-Spanne:
Value
$0.6254
$2.75

Milestone Pharmaceuticals Inc Stock (MIST) Company Profile

Name
Firmenname
Milestone Pharmaceuticals Inc
Name
Telefon
(514) 336-0444
Name
Adresse
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
Name
Mitarbeiter
33
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
MIST's Discussions on Twitter

Vergleichen Sie MIST mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MIST
Milestone Pharmaceuticals Inc
1.55 134.24M 0 -59.69M -46.54M -1.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-05 Fortgesetzt H.C. Wainwright Buy
2024-08-22 Eingeleitet Rodman & Renshaw Buy
2023-06-20 Herabstufung Jefferies Buy → Hold
2022-04-22 Hochstufung Piper Sandler Neutral → Overweight
2021-03-05 Eingeleitet H.C. Wainwright Buy
2020-07-29 Hochstufung Oppenheimer Perform → Outperform
2020-07-24 Hochstufung Jefferies Hold → Buy
2020-03-25 Herabstufung Jefferies Buy → Hold
2020-03-24 Herabstufung Oppenheimer Outperform → Perform
2020-03-24 Herabstufung Piper Sandler Overweight → Neutral
2019-06-04 Eingeleitet Oppenheimer Outperform
2019-06-03 Eingeleitet Cowen Outperform
2019-06-03 Eingeleitet Jefferies Buy
2019-06-03 Eingeleitet Piper Jaffray Overweight
Alle ansehen

Milestone Pharmaceuticals Inc Aktie (MIST) Neueste Nachrichten

pulisher
Jul 28, 2025

Published on: 2025-07-29 04:32:28 - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

How volatile is Milestone Pharmaceuticals Inc. stock compared to the marketGet exclusive market analysis for investors - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics - Business Wire

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Milestone Pharmaceuticals Inc. in the next 12 monthsFree Stock Insights For Every Investor - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Milestone Pharmaceuticals Inc. compare to its industry peersBuild wealth faster with high-performing stocks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Milestone Pharmaceuticals Inc. stockFree Capital Allocation Plans - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Milestone Pharmaceuticals Inc. stock overvalued or undervaluedSuperior returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell Milestone Pharmaceuticals Inc. stock in 2025Invest smarter with high-probability setups - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Milestone Pharmaceuticals Inc. stock price move sharplyMaximize profits with strategic stock selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Is Milestone Pharmaceuticals Inc. stock a good hedge against inflationFree Access to Group - metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Why Milestone Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Investment Discussion Area - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Atrial Fibrillation (AF) Pipeline Market Research Report 2025 | Insights on 10+ Companies and 12+ Drugs in the Pipeline Landscape - GlobeNewswire Inc.

Jul 25, 2025
pulisher
Jul 25, 2025

Is Milestone Pharmaceuticals Inc. a good long term investmentExtraordinary earning power - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Milestone Pharmaceuticals Inc. stock priceExceptional trading results - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Milestone Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is Milestone Pharmaceuticals Inc. stock a growth or value playFree Advanced Stock Screener Access - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Milestone Pharmaceuticals Inc. stockConsistently superior profits - Autocar Professional

Jul 23, 2025
pulisher
Jul 18, 2025

Milestone Pharmaceuticals Remains A Buying Opportunity Despite Recent Dilution (MIST) - Seeking Alpha

Jul 18, 2025
pulisher
Jul 18, 2025

Piper Sandler Maintains Milestone Pharmaceuticals(MIST.US) With Buy Rating, Cuts Target Price to $4 - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

HC Wainwright Has Positive Estimate for MIST Q3 Earnings - Defense World

Jul 18, 2025
pulisher
Jul 15, 2025

Milestone Pharmaceuticals plunges after pricing $52.5M offering - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

How Milestone Pharmaceuticals Inc. stock performs during market volatilityPrecision Entry Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Retail investors who have a significant stake must be disappointed along with institutions after Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) market cap dropped by US$9.0m - simplywall.st

Jul 15, 2025

Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):